AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Authors : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Year : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412

Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Authors : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Year : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1286

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Authors : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Year : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.

Authors : Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2011
Journal : Cell. Immunol.
Volume : 270(2)
Pages : 207-16

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92

A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.

Authors : De Bruyn C, Najar M, Raicevic G, Meuleman N, Pieters K, Stamatopoulos B, Delforge A, Bron D, Lagneaux L
Year : 2011
Journal : Stem Cells Dev.
Volume : 20
Pages : 3